Full Clinical Guidelines - Community First Health Plans.

More documents

Recommendations

Info

DIABETIC FOOT EXAM** **Performed Initially at Diagnosis, Annually In Primary Care FOOT HISTORY 1. Ulcers: location, time to heal, wound care necessary for healing 2. Infections: type, bacteria involved, medical treatment necessary 3. Amputations: type, time to heal, modalities used in healing process 4. Surgeries/Injuries: type, location FOOT EXAM Vascular (Vasc) Neurologic (Neuro) 1. Palpate DP, PT pulses (present or absent) 2. Temperature gradient: from ankle to toes, focal “hot spots” 3. General Color: pink, palor, rubor on dependency 4. Digital Capillary refill time: in seconds 5. ABI: for both DP & PT arteries (abnl if 10 secs) OR Biothesiometer (>25 volts)—tested at hallux 3. Tactile sensation (light touch): via cotton wool (dorsum of foot) 4. Reflexes: Achilles tendon Dermatologic (Derm) 1. General skin turgor/texture 2. Focal lesions: calluses (debride to fully assess), cracks, pigmentation 3. Interdigital: calluses, maceration 4. Nails: incurvated, nail plate thickness, coloration, inappropriate self-care Musculoskeletal (Msk) 1. General Range of Motion: ankle, subtalar, midtarsal, metarsophalangeal 2. Foot type: rectus, pes planus, pes cavus, Charcot foot 3. Digits: hammertoes, claw toes, mallet toes, bunion/hallux abductovalgus 4. Bony prominences Footwear 1. Type 2. Wear pattern: outsole and upper counter distortion 3. Insole inspection: foreign bodies, staining, excessive wear 4. Socks: foreign bodies, staining, excessive wear Social 1. Tobacco/alcohol/drug use 2. Work environment/foot demands/footwear requirements 3. Physical activities: footwear used 4. Family support: marital status, spouse/family involvement in health 5. Education: diabetes self-management Page 2 66 H EALTH PLANS www.cfhp.com
DIABETIC FOOT CARE/REFERRAL ALGORITHM Complete Diabetic Foot Exam** (see page 2) NORMAL (NL) EXAM NL vasc NL neuro NL msk NL derm MD/DO/DPM (or physician extender) DM FOOT EDUCATION -patient/family (Diabetes Self- Management Education) -verbal/written -websites -clinic phone #s ABBREVIATIONS: MD = medical doctor DO = doctor of osteopathy DPM = doctor of podiatric medicine (Podiatrist) NL = normal ABNL = abnormal ABI = ankle/brachial index TCPO2 = transcutaneous oxygen pressure NCV = nerve conduction velocities PSSD = pressure specified sensory device REPEAT Diabetic Foot Screen* -per MD, DO, physician extender visits or DPM exam REPEAT EVERY VISIT ABNORMAL (ABNL) EXAMS NORMAL testing-repeat per change in exam or onset symptoms A ABNL VASC NL neuro NL msk NL derm VASCULAR CONSULT/TESTING Consider : PVR, Seg.pres., ABI, TCPO2 -peripheral arteriogram as indicated -intervention as indicated to re-establish blood flow Documentation of vascular disease OR Post intervention with improvement -EDUCATION: signs/symptoms -HIGH RISK foot status -Foot screen every MD/DO/DPM, or physician extender visit B NL vasc ABNL NEURO NL msk NL derm NEURO or PM&R CONSULT Consider: NCV, PSSD -other causes: consider and rule out as indicated -if painful consider pharmaceutical vs. surgical treatment -EDUCATION: signs/symptoms -HIGH RISK foot status -Foot screen every MD/DO/DPM, or physician extender visit, PRN C NL vasc NL neuro ABNL MSK NL derm COMPLETE BIOMECHANICAL EXAM (Podiatrist, Orthopedist) -discuss clinical significance -Treatment options: surgical, non-surgical -EDUCATION: signs/symptoms -Intervention: surgery→healed = low risk -Biomech: shoes, orthoses, phys.medicine -Follow up DPM per modality needed -Foot screen: every MD/DO/physician extender visit D NL vasc NL neuro NL msk ABNL DERM Dystrophic (thick, discolored) toenails -Debride/reduce -Culture as needed -Educate on condition management -Referral as needed (podiatrist, dermatologist) Dry skin, fissures -Diagnostic tests as indicated, e.g. for fungus -Topicals as indicated -referral as indicated Ingrown toenail -Instruct on proper nail care -Matrixectomy if NL vasc exam Page 3 H EALTH PLANS www.cfhp.com 67
Page 1 and 2:
Community First Health Plans Qualit
Page 3 and 4:
10.5 ATP III Classification of Chol
Page 5 and 6:
Such information is released only t
Page 7 and 8:
Non Voting • Martin Jimenez, Dire
Page 9 and 10:
The purpose of these guidelines is
Page 11 and 12:
Table 1. Adult Preventive Services
Page 13 and 14:
Recommended Adult Immunization Sche
Page 15 and 16: Footnotes — Recommended Adult Imm
Page 17 and 18: CFHP has adopted the National Asthm
Page 19 and 20: Patient Name ______________________
Page 21 and 22: Managing Asthma Long Term 41 FIGURE
Page 23 and 24: FIGURE 14. CLASSIFYING ASTHMA SEVER
Page 25 and 26: FIGURE 16. STEPWISE APPROACH FOR MA
Page 27 and 28: FIGURE 20. CLASSIFYING SEVERITY OF
Page 29 and 30: II. Some hyperactive-impulsive or i
Page 31 and 32: COMMUNITY FIRST HEALTH PLANS BEHAVI
Page 33 and 34: Criteria Requirements 33. Release o
Page 35 and 36: The evaluation of breast disease is
Page 37 and 38: Prevent Child Texas, a non-profit o
Page 39 and 40: AMERICAN ACADEMY OF PEDIATRICS: Fai
Page 41 and 42: possible), a careful, complete, and
Page 43 and 44: Examination/Test Oral / Dental Insp
Page 45 and 46: GLYCEMIC CONTROL BIBLIOGRAPHY • R
Page 47 and 48: Publication # 45-11647 Targets* A1
Page 49 and 50: WORKSHEET Revised 10-20-05 Advancin
Page 51 and 52: D. Optimizing analog insulin use Re
Page 53 and 54: Publication # 45-11266 Age 126 mg/d
Page 55 and 56: Hypertension Algorithm for Diabetes
Page 57 and 58: Lipid Algorithm For Type 1 and Type
Page 59 and 60: References: Revised 1-24-08 • Col
Page 61 and 62: WEIGHT LOSS ALGORITHM FOR OVERWEIGH
Page 63 and 64: Publication #45-11825 Screening 1 :
Page 65: Publication #45-12000 DIABETIC FOOT
Page 69 and 70: Publication # 45-12083 WEIGHT MANAG
Page 71 and 72: 9 H EALTH PLANS www.cfhp.com 71
Page 73 and 74: Revised 10-25-07 IV INSULIN INFUSIO
Page 75 and 76: Revised 10-25-07 Publication #: 45-
Page 77 and 78: Revised 2-21-08 Publication #: E45-
Page 79 and 80: Abbreviations AGI Alpha-Glucosidase
Page 81 and 82: Orders for Adults with DKA and Hype
Page 83 and 84: D i a b e t e s t r e a t m e n t a
Page 85 and 86: CFHP has adopted the National Insti
Page 87 and 88: No CHD; 0 to 1, or 2+ Risk Factors
Page 89 and 90: NATIONAL CHOLESTEROL EDUCATION PROG
Page 91 and 92: NATIONAL CHOLESTEROL EDUCATION PROG
Page 93 and 94: Identification, Evaluation, and Tre
Page 95 and 96: 11.3 Treatment of Hypertension H EA
Page 97 and 98: ALGORITHM FOR TREATMENT OF MAJOR DE
Page 99 and 100: CFHP has established guidelines for
Page 101 and 102: A. Documentation ______ B. Continui
Page 103 and 104: CFHP PCP MEDICAL RECORD REVIEW TOOL
Page 105 and 106: 13.3 Specialist Medical Record Docu
Page 107 and 108: 13.4 Specialist Medical Record Revi
Page 109 and 110: Risk Factors for Osteoporosis Fract
Page 111 and 112: It is well documented that obesity
Page 113 and 114: CLASSIFICATION OF OVERWEIGHT AND OB
Page 115 and 116: 16.1.1 Preventive Pediatric Health
Page 117 and 118:
H EALTH PLANS www.cfhp.com 117
Page 119 and 120:
TEXAS MEDICAID PROVIDER PROCEDURES
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
CHILDREN’S SERVICES HANDBOOK P h
Page 127 and 128:
CHILDREN’S SERVICES HANDBOOK P R
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
H EALTH PLANS www.cfhp.com 139
Page 141 and 142:
FIGURE 2: Recommended immunization
Page 143 and 144:
Comprehensive antepartum care is vi
Page 145 and 146:
The following variables should be e
Page 147 and 148:
CRITERIA 19. Unresolved Problems Fr
Page 149 and 150:
CFHP OB/GYN SPECIALTY MEDICAL RECOR
Page 151 and 152:
CFHP OB/GYN SPECIALTY MEDICAL RECOR
Page 153 and 154:
According to the National Institute
Page 155 and 156:
. aminotransferase (AST) and alanin
Page 157 and 158:
PREVENTION RECOMMENDATIONS 1. The E
Page 159 and 160:
2 to 20 years: Boys Body mass index
Page 161 and 162:
AsthmaMatters is an initiative deve
Page 163 and 164:
According to the Centers for Diseas
show all

Full Clinical Guidelines - Community First Health Plans.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?